Jagsonpal Pharmaceuticals standalone net profit rises 97.54% in the September 2020 quarter

Sales rise 34.78% to Rs 56.35 crore
Net profit of Jagsonpal Pharmaceuticals rose 97.54% to Rs 4.01 crore in the quarter ended September 2020 as against Rs 2.03 crore during the previous quarter ended September 2019. Sales rose 34.78% to Rs 56.35 crore in the quarter ended September 2020 as against Rs 41.81 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales56.3541.81 35 OPM %8.596.03 -PBDT5.132.81 83 PBT4.862.54 91 NP4.012.03 98Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 10 2020 | 3:25 PM IST
